New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Enliven Therapeutics, Inc.
ELVN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

1B

Biotechnology

23.61USD
Shape-0.82 ( -3.36%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-20%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

21%

Quote Panel

Shape
Updated December 4, 2024
1W -3.16 % 1M -15.71 % 3M 7.76 % 1Y 109.87 %

Key Metrics

Shape
  • Market Cap

    1.15B


  • Shares Outstanding

    48.86M


  • Share in Float

    30.23M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    23.61


  • Average Volume

    258953


  • Beta

    0.931


  • Range

    9.8-30.03


  • Industry

    Biotechnology


  • Website

    https://www.enliventherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2616.74x

P/S Ratio

3.94x

P/B Ratio

0.0

Debt/Equity

-19366.8%

Net Margin

$-1.9

EPS

How ELVN compares to sector?

P/E Ratio

Relative Strength

Shape

ELVN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10K

ShapeNaN%

2025-Revenue

$2.32

Shape-384%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

H.C. Wainwright

initialise

Previous: Not converted

2024-09-09

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+158%

1.23
vs -2.12

Q1.23

arrow
arrow

N/A

-0.80
vs -2.24

Q2.23

arrow
arrow

N/A

-0.41
vs -1.76

Q3.23

arrow
arrow

N/A

-0.51
vs -0.72

Q4.23

arrow
arrow

N/A

-0.47
vs 1.23

Q1.24

arrow
arrow

N/A

-0.54
vs -0.80

Q2.24

arrow
arrow

N/A

-0.41
vs -0.41

Q3.24

arrow
arrow

N/A

-0.48
vs -0.51

Q4.24

arrow
arrow

N/A

-0.52
vs -0.47

Q1.25

arrow
arrow

N/A

-0.56
vs -0.54

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

440K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+36%

0.36
vs 0.15

Q1.23

arrow
arrow

-4%

-0.04
vs 0.36

Q2.23

arrow
arrow

-6%

-0.06
vs -0.04

Q3.23

arrow
arrow

-8%

-0.08
vs -0.06

Q4.23

arrow
arrow

-8%

-0.08
vs -0.08

Q1.24

arrow
arrow

-7%

-0.07
vs -0.08

Q2.24

arrow
arrow

-7%

-0.07
vs -0.07

Q3.24

arrow
arrow

-8%

-0.08
vs -0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News